{"id":62728,"date":"2026-04-09T20:26:32","date_gmt":"2026-04-09T12:26:32","guid":{"rendered":"https:\/\/flcube.com\/?p=62728"},"modified":"2026-04-09T20:26:35","modified_gmt":"2026-04-09T12:26:35","slug":"gan-lee-licenses-bonfaglutide-to-jw-pharma-for-81-1m-expands-glp-1-footprint-into-south-korea","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=62728","title":{"rendered":"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea"},"content":{"rendered":"\n<p><strong>Gan &amp; Lee Pharmaceuticals<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/603087:SHA\">SHA:\u202f603087<\/a>) announced a <strong>licensing agreement<\/strong> with <strong>JW Pharmaceutical<\/strong>, granting the South Korean firm <strong>exclusive development and commercialization rights<\/strong> to <strong>bonfaglutide<\/strong>, Gan &amp; Lee&#8217;s in\u2011house developed <strong>long\u2011acting GLP\u20111 receptor agonist<\/strong>, for <strong>type\u202f2 diabetes (T2D) and weight management<\/strong> indications in <strong>South Korea<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-structure\">Transaction Structure<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Value<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Upfront Payment<\/strong><\/td><td><strong>US$5\u202fmillion<\/strong><\/td><td>One\u2011time, non\u2011refundable<\/td><\/tr><tr><td><strong>Milestone Payments<\/strong><\/td><td><strong>US$76.1\u202fmillion<\/strong><\/td><td>Tied to development, regulatory approvals, commercialization<\/td><\/tr><tr><td><strong>Royalties<\/strong><\/td><td>Tiered<\/td><td>On net sales post\u2011launch<\/td><\/tr><tr><td><strong>Total Deal Value<\/strong><\/td><td><strong>US$81.1\u202fmillion<\/strong><\/td><td>Aggregate potential consideration<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-profile\">Product Profile<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Molecule:<\/strong> <strong>Bonfaglutide<\/strong> \u2013 Long\u2011acting <strong>GLP\u20111 receptor agonist<\/strong><\/li>\n\n\n\n<li><strong>Developer:<\/strong> Gan &amp; Lee Pharmaceuticals (internal R&amp;D)<\/li>\n\n\n\n<li><strong>Indications:<\/strong> Type\u202f2 diabetes (T2D) + weight management<\/li>\n\n\n\n<li><strong>Mechanism:<\/strong> Enhances glucose\u2011dependent insulin secretion, suppresses glucagon, delays gastric emptying, reduces appetite<\/li>\n\n\n\n<li><strong>Competitive Position:<\/strong> Positioned within the <strong>US$30\u202fbillion+ global GLP\u20111 market<\/strong> dominated by Novo Nordisk and Eli Lilly<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-expansion\">Strategic Expansion<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Region<\/th><th>Partner<\/th><th>Status<\/th><\/tr><\/thead><tbody><tr><td><strong>Latin America<\/strong><\/td><td>Undisclosed<\/td><td>Active partnership<\/td><\/tr><tr><td><strong>India<\/strong><\/td><td>Undisclosed<\/td><td>Active partnership<\/td><\/tr><tr><td><strong>South Korea<\/strong><\/td><td><strong>JW Pharmaceutical<\/strong><\/td><td><strong>New deal (Apr\u202f2026)<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>This marks Gan &amp; Lee&#8217;s <strong>third out\u2011licensing transaction<\/strong> for bonfaglutide, demonstrating sustained international demand for its GLP\u20111 asset.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-outlook\">Market Context &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Korea GLP\u20111 Market:<\/strong> South Korea represents a <strong>US$400\u202fmillion+ annual market<\/strong> for GLP\u20111 therapies, with obesity coverage expanding under national health insurance.<\/li>\n\n\n\n<li><strong>JW Pharma Fit:<\/strong> Established Korean pharmaceutical company with proven metabolic disease commercialization infrastructure and endocrinology specialist network.<\/li>\n\n\n\n<li><strong>Gan &amp; Lee Strategy:<\/strong> Asset\u2011light international expansion via licensing preserves capital while capturing milestone and royalty upside; retains full rights for <strong>Greater China<\/strong> core market.<\/li>\n\n\n\n<li><strong>Pipeline Validation:<\/strong> Repeated out\u2011licensing deals signal bonfaglutide&#8217;s competitive clinical profile; potential <strong>US\/EU partnership<\/strong> could follow pending Phase\u202fIII data readouts.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding milestone achievements, regulatory timelines, and commercial projections for bonfaglutide. Actual results may differ due to risks including clinical trial failures, regulatory rejections, competitive market entry, and partner performance.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gan &amp; Lee Pharmaceuticals (SHA:\u202f603087) announced a licensing agreement with JW Pharmaceutical, granting the South&#8230;<\/p>\n","protected":false},"author":1,"featured_media":62729,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[39,421,3544,86,1120],"class_list":["post-62728","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-diabetes","tag-gan-lee-pharmaceuticals","tag-jw-pharmaceutical","tag-obesity","tag-sha-603087"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Gan &amp; Lee Pharmaceuticals (SHA:\u202f603087) announced a licensing agreement with JW Pharmaceutical, granting the South Korean firm exclusive development and commercialization rights to bonfaglutide, Gan &amp; Lee&#039;s in\u2011house developed long\u2011acting GLP\u20111 receptor agonist, for type\u202f2 diabetes (T2D) and weight management indications in South Korea.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=62728\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea\" \/>\n<meta property=\"og:description\" content=\"Gan &amp; Lee Pharmaceuticals (SHA:\u202f603087) announced a licensing agreement with JW Pharmaceutical, granting the South Korean firm exclusive development and commercialization rights to bonfaglutide, Gan &amp; Lee&#039;s in\u2011house developed long\u2011acting GLP\u20111 receptor agonist, for type\u202f2 diabetes (T2D) and weight management indications in South Korea.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=62728\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-09T12:26:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-09T12:26:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0904.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea\",\"datePublished\":\"2026-04-09T12:26:32+00:00\",\"dateModified\":\"2026-04-09T12:26:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728\"},\"wordCount\":332,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/0904.webp\",\"keywords\":[\"Diabetes\",\"Gan &amp; Lee Pharmaceuticals\",\"JW Pharmaceutical\",\"Obesity\",\"SHA: 603087\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62728#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=62728\",\"name\":\"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/0904.webp\",\"datePublished\":\"2026-04-09T12:26:32+00:00\",\"dateModified\":\"2026-04-09T12:26:35+00:00\",\"description\":\"Gan & Lee Pharmaceuticals (SHA:\u202f603087) announced a licensing agreement with JW Pharmaceutical, granting the South Korean firm exclusive development and commercialization rights to bonfaglutide, Gan & Lee's in\u2011house developed long\u2011acting GLP\u20111 receptor agonist, for type\u202f2 diabetes (T2D) and weight management indications in South Korea.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62728\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/0904.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/0904.webp\",\"width\":1080,\"height\":608,\"caption\":\"Gan & Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62728#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea - Insight, China&#039;s Pharmaceutical Industry","description":"Gan & Lee Pharmaceuticals (SHA:\u202f603087) announced a licensing agreement with JW Pharmaceutical, granting the South Korean firm exclusive development and commercialization rights to bonfaglutide, Gan & Lee's in\u2011house developed long\u2011acting GLP\u20111 receptor agonist, for type\u202f2 diabetes (T2D) and weight management indications in South Korea.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=62728","og_locale":"en_US","og_type":"article","og_title":"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea","og_description":"Gan & Lee Pharmaceuticals (SHA:\u202f603087) announced a licensing agreement with JW Pharmaceutical, granting the South Korean firm exclusive development and commercialization rights to bonfaglutide, Gan & Lee's in\u2011house developed long\u2011acting GLP\u20111 receptor agonist, for type\u202f2 diabetes (T2D) and weight management indications in South Korea.","og_url":"https:\/\/flcube.com\/?p=62728","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-09T12:26:32+00:00","article_modified_time":"2026-04-09T12:26:35+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0904.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=62728#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=62728"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea","datePublished":"2026-04-09T12:26:32+00:00","dateModified":"2026-04-09T12:26:35+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=62728"},"wordCount":332,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=62728#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0904.webp","keywords":["Diabetes","Gan &amp; Lee Pharmaceuticals","JW Pharmaceutical","Obesity","SHA: 603087"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=62728#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=62728","url":"https:\/\/flcube.com\/?p=62728","name":"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=62728#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=62728#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0904.webp","datePublished":"2026-04-09T12:26:32+00:00","dateModified":"2026-04-09T12:26:35+00:00","description":"Gan & Lee Pharmaceuticals (SHA:\u202f603087) announced a licensing agreement with JW Pharmaceutical, granting the South Korean firm exclusive development and commercialization rights to bonfaglutide, Gan & Lee's in\u2011house developed long\u2011acting GLP\u20111 receptor agonist, for type\u202f2 diabetes (T2D) and weight management indications in South Korea.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=62728#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=62728"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=62728#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0904.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0904.webp","width":1080,"height":608,"caption":"Gan & Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=62728#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Gan &amp; Lee Licenses Bonfaglutide to JW Pharma for $81.1M \u2013 Expands GLP\u20111 Footprint into South Korea"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0904.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62728"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62728\/revisions"}],"predecessor-version":[{"id":62730,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62728\/revisions\/62730"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/62729"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}